Founder, managing director and member of the Board of Directors of DoseVue NV.
Emiliano holds a master in nuclear engineering from the Politecnico di Milano and a second master in physics engineering from the Free University Brussels (ULB). He also obtained a PhD in biomedical/ electrical engineering from the University of Leuven.
Emiliano has worked several years in the fields of medical imaging and of patient dosimetry.
He has also followed several business master classes.
Staf Van Reet
Staf Van Reet
Staf, Executive Chairman of DoseVue N.V. (on behalf of VIZIPhar Biosciences B.V.B.A.) was formerly active as Managing Director of Janssen Pharmaceutica N.V., Head of R&D of the Janssen Group and a member of the Group Operating Committee of the pharmaceutical sector of Johnson & Johnson.
From 2000 until 2004 Staf was Vice President of the Johnson & Johnson Development Corporation, the venturing arm of Johnson & Johnson. He was a co-founder of Movetis N.V. and Chairman of its Board of Directors until November 2010, when the company was acquired by Shire S.a.r.l..
Currently, Staf is Chairman of the Board of Directors of Thrombogenics N.V. ,Actogenix N.V. and the Flemish Institute for Biotechnology (VIB) and a Director of Biocartis S.A., and Therasolve N.V..
Staf obtained the degrees of Master and PhD in Bio-engineering Sciences from the University of Leuven.